Nicotinic acid activates the capsaicin receptor TRPV1: Potential mechanism for cutaneous flushing.
Level 5 - mechanism / opinion, no new human data
Preclinical laboratory and animal knockout study without human data
PubMed 24675661 · doi:10.1161/ATVBAHA.113.303346
What was done
The authors investigated whether nicotinic acid (niacin) induces cutaneous vasodilation through activation of the capsaicin receptor TRPV1. They measured nicotinic acid-induced blood flow responses in Trpv1-knockout mice and performed in vitro assays on exogenously expressed TRPV1 channels, assessing intracellular channel activation, heat threshold modulation, ligand interactions, and transporter-mediated cellular entry via live-cell fluorescence imaging.
What was found
Nicotinic acid-induced increases in blood flow were substantially reduced in Trpv1-knockout mice. In cell models, nicotinic acid at submillimolar to millimolar concentrations directly activated TRPV1 from the intracellular side, lowered the channel thermal activation threshold to cause opening at physiological temperatures, and potentiated activation by voltage, capsaicin, and 2-aminoethoxydiphenyl borate. Nicotinic acid entered cells rapidly via a transporter-mediated pathway. The abstract reported no exact numerical values or sample sizes.
Why it matters
This study identifies direct intracellular TRPV1 activation as a molecular mechanism contributing to niacin-induced flushing, providing a potential target to alleviate a major side effect that limits adherence to dyslipidemia therapy.
Limits
The study is entirely preclinical, relying on in vitro expression models and mice, with no human participants. The abstract lacks sample sizes, effect sizes, statistical confidence intervals, and quantitative measures of how much TRPV1 contributes to flushing relative to known prostaglandin pathways in humans.
Cited by
- supports High doses of nicotinic acid cause cutaneous flushing and hot-flash-like symptoms.